Full-Time

Material Handler

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Compensation Overview

$45k - $60kAnnually

Entry

Sacramento, CA, USA

Onsite position in Sacramento, CA, with shifts from Monday to Friday.

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Inventory Management
Requirements
  • Minimum of high school diploma or GED
  • A.S. degree is preferred, but not required
  • Experience with material management systems
  • Experience in warehouse operations and material movements
  • Cell and gene therapy knowledge is beneficial
Responsibilities
  • Receive, inspect and verify incoming materials against orders and documentation
  • Ensure materials are moved and stored in their correct locations
  • Maintain accurate inventory records, perform cycle counts, and manage material expiration
  • Prepare consumable materials kits for use in production
  • Movement and transfer of materials including drug products and samples from production
  • Maintenance of consumable gowning stock across various facility locations
  • Receipt and incoming donor cells and shipment of patient drug productions
  • Execution of cold storage practices and cryopreservation of drug products when needed

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to advance cell therapy treatments, addressing conditions that currently have limited effective options.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

11%

1 year growth

16%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?